614 The proteomic classifier VeriStrat® identifies advanced non small cell lung cancer (NSCLC) patients gaining clinical benefit from treatment with first line sorafenib and erlotinib

✍ Scribed by E. Smit; H. Roder; J. Grigorieva; J. Roder; J. Lind; A. Dingemans; H. Groen

• Book ID: 119603297
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 78 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(10)72321-1